Sensydia completes enrollment in study for AI-powered cardiac monitoring device
/Sensydia announced today that it completed enrollment in its 225-subject development study for its AI-powered Cardiac Performance System (CPS).
Los Angeles-based Sensydia designed the AI-based, non-invasive CPS to use heart sound analysis. It may enable earlier detection and improved therapy guidance for heart failure and pulmonary hypertension patients.
CPS uses ultra-sensitive biosensors for the rapid, non-invasive measurement of a number of cardiac metrics. These include ejection fraction, cardiac output, pulmonary artery pressure and pulmonary capillary wedge pressure. It all comes together in one handheld device, Sensydia said.